PTC Therapeutics Archives - Market Exclusive

Home Tags PTC Therapeutics

Analyst Activity – William Blair Reiterates Hold on PTC Therapeutics (NASDAQ:PTCT)

ME Staff - March 7, 2018

Analyst Activity – Citigroup Raises Its Price Target On PTC Therapeutics...

ME Staff - February 21, 2018

Analyst Activity – Royal Bank of Canada Initiates Coverage On PTC...

ME Staff - January 29, 2018

Analyst Activity – Barclays Reiterates Hold on PTC Therapeutics (NASDAQ:PTCT)

ME Staff - January 23, 2018

Analyst Activity – Citigroup Inc. Reiterates Buy on PTC Therapeutics (NASDAQ:PTCT)

ME Staff - July 20, 2017

BioMarin, Sarepta’s Loss Could Be PTC’s Gain

Roger Hannington - January 18, 2016

/* */

EDITOR PICKS

Cannabis Stock News Daily Roundup April 12

April 12, 2019

Market Morning: Alexa Spying, Boeing Sensor History, Macron Spoils Scallop Dinner

April 11, 2019

ICC, AgraFlora to Bring Native Colombian Cannabis Strains to 39K Retail...

April 10, 2019

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: PTC Therapeutics